LIXT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lixte Biotechnology Holdings Inc (LIXT) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are mixed, with a bearish moving average trend and no clear upward momentum. Additionally, the company's financial performance remains weak, with negative income and declining EPS. There are no significant trading trends, news catalysts, or analyst ratings to support a buy decision. Given the lack of positive signals and the investor's preference for long-term growth, it is better to hold off on investing in this stock.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 2.926, with resistance at 3.186 and support at 2.666. Overall, the technical indicators do not strongly support a buy decision.
The MACD indicates some bullish momentum, and there is a 5.28% chance of a positive price movement in the next month.
Bearish moving averages, no recent news or trading trends, weak financial performance, and no significant institutional or insider activity.
In Q3 2025, revenue remained at 0 with no growth. Net income improved by 105.95% YoY but remains negative at -2,030,765. EPS declined by -25.00% YoY to -0.33. Gross margin is 0, indicating no profitability.
No analyst ratings or price target changes available.
